These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Incidence and management of gastrointestinal bleeding with continuous flow assist devices. Aggarwal A, Pant R, Kumar S, Sharma P, Gallagher C, Tatooles AJ, Pappas PS, Bhat G. Ann Thorac Surg; 2012 May; 93(5):1534-40. PubMed ID: 22541185 [Abstract] [Full Text] [Related]
24. Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Wever-Pinzon O, Selzman CH, Drakos SG, Saidi A, Stoddard GJ, Gilbert EM, Labedi M, Reid BB, Davis ES, Kfoury AG, Li DY, Stehlik J, Bader F. Circ Heart Fail; 2013 May; 6(3):517-26. PubMed ID: 23479562 [Abstract] [Full Text] [Related]
27. Outcomes and Predictors of Readmissions with GI Bleeding in Patients with Left Ventricular Assist Devices. Shah R, Qayed E. South Med J; 2018 Nov; 111(11):666-673. PubMed ID: 30392001 [Abstract] [Full Text] [Related]
30. Long-term discontinuation of antithrombotic therapy in patients with HeartMate II continuous-flow left ventricular assist device support. Schurr JW, Seifert FC, McLarty AJ. Int J Artif Organs; 2019 Dec; 42(12):770-774. PubMed ID: 31298625 [Abstract] [Full Text] [Related]
31. Gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices: A comprehensive review. Del Rio-Pertuz G, Nair N. Artif Organs; 2023 Jan; 47(1):12-23. PubMed ID: 36334280 [Abstract] [Full Text] [Related]
32. Gastrointestinal bleeding with continuous-flow left ventricular assist devices. Amer S, Shah P, Hassan S. Clin J Gastroenterol; 2015 Apr; 8(2):63-7. PubMed ID: 25614135 [Abstract] [Full Text] [Related]
33. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L. Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167 [Abstract] [Full Text] [Related]
36. Pentoxifylline for the treatment of hemolytic anemia in a patient who developed recurrent gastrointestinal bleeding while on continuous-flow left ventricular assist device support. Jennings DL, Williams CT, Morgan JA. ASAIO J; 2013 Oct; 59(5):526-7. PubMed ID: 23896772 [Abstract] [Full Text] [Related]
37. Relationship Between Anticoagulation Intensity and Thrombotic or Bleeding Outcomes Among Outpatients With Continuous-Flow Left Ventricular Assist Devices. Nassif ME, LaRue SJ, Raymer DS, Novak E, Vader JM, Ewald GA, Gage BF. Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27154497 [Abstract] [Full Text] [Related]
38. Association of Nasal Mucosal Vascular Alterations, Gastrointestinal Arteriovenous Malformations, and Bleeding in Patients With Continuous-Flow Left Ventricular Assist Devices. Patel SR, Madan S, Saeed O, Algodi M, Luke A, Gibber M, Goldstein DJ, Jorde UP. JACC Heart Fail; 2016 Dec; 4(12):962-970. PubMed ID: 27744088 [Abstract] [Full Text] [Related]
39. Octreotide for recurrent intestinal variceal bleeding in patients without portal hypertension. Dray X, Vahedi K, Odinot JM, Marteau P. Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):836-9. PubMed ID: 19381096 [Abstract] [Full Text] [Related]